阿尔茨海默氏病的细胞类型特定的主代谢调节剂
Yunguang Qiu1,2, Yuan Hou1,2, Liam Wetzel3
1Cleveland Clinic Genome Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
bioRxiv : the preprint server for biology
|August 12, 2025
概括
阿尔茨海默病显示大脑细胞之间的代谢差异. 一个名为scFUMES的新算法识别了关键的代谢调节者,揭示了阿尔茨海默病 (AD) 的潜在治疗点.
科学领域:
- 神经科学是一个神经科学.
- 代谢学 代谢学 代谢学
- 系统生物学 系统生物学
背景情况:
- 阿尔茨海默氏病 (AD) 呈现代谢异质性,但细胞类型特定的代谢动态和调节网络尚未得到充分理解.
- 神经元显示能量和脂质代谢的减少,而微质表现出与AD神经炎症相关的代谢增加.
研究的目的:
- 为了确定细胞类型特定的主代谢调节者,驱动阿尔茨海默氏病中的代谢变化.
- 开发和应用一个新的算法, scFUMES,用于分析复杂的代谢网络在AD.
主要方法:
- 开发了scFUMES (单细胞功能代谢物传感器) 算法,集成多omics数据 (scRNA-seq,互动组学,基因组学,转录组学,代谢组学).
- 将 scFUMES 应用于人类大脑的生物库数据,这些数据来自AD易受伤害的区域 (中圈,背侧前额皮层).
- 通过实验测试验证了预测的代谢调节器相互作用.
主要成果:
- scFUMES发现了数百种与AD相关的代谢调节剂,神经元和微质细胞显示了最多的相互作用.
- 在AD的严重程度,性别和APOE基因型中,精确指明了基因信息的主调节器 (例如微中的PPARD-糖).
- 实验验证证证实了两个预测的相互作用 (神经PFN3和肠道代谢物IPA) 降低了AD的病理性tau物种.
结论:
- scFUMES提供了阿尔茨海默病中主要代谢调节者的系统地图.
- 突出了细胞代谢异质性在AD病变发生过程中的作用.
- 为阿尔茨海默病和相关痴呆症提供了新的见解和潜在的治疗策略.
更多相关视频
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
664
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.0K
相关概念视频
Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668
Master Transcription Regulators
7.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
Alzheimer's Disease: Treatment
261
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
261
Regulation of Metabolism
9.9K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.9K
Role of Neurotransmitters in Memory
978
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
978
